The effects of electroconvulsive therapy on melatonin

Journal of ECT

Volumn 16, Issue 4, 2000, Pages 391-398

  Krahn, Lois E ^a,c   Gleber, Eileen ^b   Rummans, Teresa A ^a   Pileggi, Thomas S ^a   Lucas, Darlene L ^a   Li, Hongzhe ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

6 Sulfatoxymelatonin; Electroconvulsive therapy; Major depression; Melatonin

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; 6-SULFATOXYMELATONIN; ANTIOXIDANT; DRUG DERIVATIVE; MELATONIN;

ADULT; AGED; ARTICLE; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; TREATMENT OUTCOME; URINE;

ADULT; AGED; ANTIOXIDANTS; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0034574757     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-200012000-00009     Document Type: Article

References (34)

1. Arendt J. Mammalian pineal rhythms. Pineal Res Rev 1985;3:151-213.
2. Arendt J. Melatonin. Clin Endocrinology 1988;29:205-29.
3. Axelrod J. The pineal gland: a neurochemical transducer. Science 1974;184:1341-8.
4. Bojkowski CJ, Allhous ME, English J, Franey C, Poulton AL, Skene DJ, Arendt J. Suppression of nocturnal plasma melatonin and 6-sulfatoxymelatonin by bright and dim light in man. Horm Metab Res 1987;19: 437-40.
5. Beck-Friis J, Ljunggren J-G, Thoren M, von Rosen D, Kjellman BF, Wetterberg L. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of dexamethasone suppression tests. Psychoneuroendocrinology 1985;10:173-86.
6. Bojkowski CJ, Arendt J, Shih MC, Markey SP. Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin. Clin Chem 1987;33:1343-8.
7. Broadway J, Arendt J, Folkard S. Bright light phase shifts the human melator in rhythm during the Antarctic winter. Neurosci Lett 1987;79:185-9.
8. Brown RP, Kocsis JH, Caroff S, Amsterdam J, Winokur A, Stokes P, Frazer A. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am J Psychiatry 1985;142: 811-16.
9. Claustrat B, Chazot G, Brun J, Jordan D, Sassolas G. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 1984;19:1215-28.
10. Checkley SA, Park SBG. The psychopharmacology of the human pineal. J Psychopharmacol 1987;2:109-25.
11. Demisch K, Demisch L, Bochnick HL, et al. Melatonin and cortisol increases after fluvoxamine. Br J Clin Pharmacol 1986;22:620-2.
12. Fochtmann LJ. Animal studies of electroconvulsive therapy: foundations for future research. Psychopharmacol Bull 1994;30:321-81.
13. Kennedy SH, Brown GM, Ford CJ, Ralevski E. The acute effects of starvation on 6-sulfatoxymelatonin output in subgroups of patients with anorexia nervosa. Psychoneuroendocrinology 1993;19:131-9.
14. Klein DC, Coon SL, Roseboom PH, et al. The melatonin rhythm-generating enzyme: molecular regulation of serotonin N-acetyltransferase in the pineal gland. Rec Progress Norm Res 1997;52:307-57.
15. Kopin IJ, Pare CMB, Axelrod J, Weissback M. The fall of melatonin in animals. J Biol Chem 1961;236:3072-75.
16. Lane EA, Moss HB. Pharmacokinetics of melatonin in man: first pass hepatic metabolism. J Clin Endocrinol Metab 1985;61:1214-16.
17. Lewy AJ, Newsome DA. Different types of melatonin circadian secretory rhythms in some blind subjects. J Clin Endocrinol Metab 1983;56:1103-7.
18. Linnoila M, Litovitz G, Scheinin M, Chang M, Cutler NR. Effects of ECT on monoamine metabolites, growth hormone, and prolactin in plasma. Biol Psych 1984;19:79-84.
19. Mann JJ, Kapur S. Elucidation of biochemical basis of the antidepressant action of electroconvulsive therapy by human studies. Psychopharmacol Bull 1994;30:445-53.
20. Markey SP, Higa S, Shih M, Danforth TN, Tamarkin L. The correlation between human plasma melatonin and urinary 6-sulfatoxymelatonin excretion. Clinica Chim Acta 1985;140:221-5.
21. McIntyre IM, Norman TR, Burrows GD, Armstrong SM. Human melatonin suppression by light is intensity dependent. J Pineal Res 1989;6:149-56.
22. Miles A, Philbrick DRS. Melatonin and psychiatry. Biol Psychiatry 1988:23:405-25.
23. Monteleone P, D'Istria M, De Luca B, Serino I, Maj M, Kemali D. Pineal response to isoproterenol in rats chronically treated with electroconvulsive shock. Brain Res Bull 1993;31:257-59.
24. Monteleone P, Steardo L, D'Istria M Serion I, Maj M. Effects of single and repeated electroconvulsive shock on isoproterenol-stimulated pineal N-acetyltransferase activity and melatonin production in rats. Pharmacol Biochem Behav 1995;50:241-4.
25. Ravidran AV, Bialik RJ, Brown GM, Lapierre YD. Primary early onset dysthymia, biological correlates of the therapeutic response to fluoxetine: II. Urinary metabolites of serotonin, norepinephrine, epinephrine and melatonin. J Affective Disord 1994;31:119-23.
26. Reiter R. Pineal rhythmicity: neural, behavioral and endocrine consequences. In: Shafii M, Shafii SL, eds. Biological Rhythms, Mood Disorders, Light Therapy and the Pineal Gland (progress in psychiatry series). Washington DC: American Psychiatric Association, Press, Inc. 1990;40-67.
27. Rubin RT, Heist EK, McGeoy SS, Hanada K, Lesser IM. Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects. Arch Gen Psychiatry 1992;49:558-67.
28. Sack RL, Lewy AJ. Melatonin and major affective disorders. In: Miles A, Philbrick D, Thompson C, eds. Melatonin: Clinical Perspectives. New York: Oxford Medical Publications, 1988:205-27.
29. Skene DJ, Bojkowski C, Arendt J. Comparison of effects of acute fluvoxamine and disipramine administration on melatonin and cortisol production in humans. Br J Clin Pharmacol 1994;37:181-6.
30. Swartz C. Neuroendocrine effects of electroconvulsive therapy (ECT). Psychopharmacol Bull 1997;33:265-71.
31. Thompson C, Franey C, Arendt J, Checkley SA. A comparison of melatonin secretion in depressed patients and normal subjects. Br J Psychiatry 1988;152:260-5.
32. Trindor J, Armstrong SM, O'Brien C, et al. Inhibition of melatonin secretion onset by low levels of illumination. J Sleep Res 1996;5:77-82.
33. Waldhauser F, Ehrhart B, Forster E. Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions. Experientia 1993;49:671-81.
34. Zetin M, Potkin S, Urbanchek M. Melatonin in depression. Psychiatry Ann 1987;17:676-81.